Merck & Co (MSD) and Eisai are set to discontinue their Phase III clinical trial for unresectable, non‑metastatic hepatocellular carcinoma (HCC) as Keytruda (pembrolizumab) plus Lenvima (lenvatinib), along with transarterial chemoembolisation (TACE), …

… global clinical development lead at Eisai. "For years, … in liver cancer research, Eisai remains committed to advancing … with TACE. All study drugs were continued until protocol-specified … , discovered and developed by Eisai, is an orally available …

MSD and Eisai's combination of Keytruda … developing it as a partner drug to Keytruda. The combination has … global clinical development lead at Eisai. "With LEAP-012, we …

(Reuters) -Merck and Japan’s Eisai said on Wednesday they will … tested Merck’s blockbuster drug Keytruda and Eisai’s Lenvima, along with …

… , claiming that it hid the drug’s link to autism. The … past year. (CNBC)  Merck-Eisai’s kidney drug combo has shown mixed … edition of Five things for pharma marketers to know, click here …

Bengaluru: Merck and Eisai's experimental combination … Merck's Welireg and Eisai's Lenvima has not … #39; approved treatment Cabometyx, the drugmakers said on Tuesday. Overall survival … a treatment works. Merck and Eisai said they would continue to …

… use of its kidney cancer drug Welireg after it hit … a combination of Welireg and Eisai’s Lenvima helped delay progression … with a type of targeted drug like Cabometyx. Under its … Arcus Biosciences, meanwhile, has a drug called casdatifan that’s similar …

(Reuters) -Merck and Eisai’s experimental combination treatment … of Merck’s Welireg and Eisai’s Lenvima, however, failed … ’ approved treatment Cabometyx, the drugmakers said on Tuesday. Overall survival … or Cabometyx. Merck and Eisai plan to present the data …

(Reuters) -Merck and Eisai’s experimental combination treatment helped … a late-stage study, the drugmakers said on Tuesday. However, the … of Merck’s Welireg and Eisai’s Lenvima failed to meet …

… societies are urging Canada’s Drug Agency and provincial governments to … a news release from manufacturer Eisai Co., Ltd., said on … global Phase 3 clinical trial, Eisai said in the release, … Frank, who has consulted for Eisai Canada, said symptoms can include …